/PRNewswire/ Recently, DAS Solar announced the official establishment of the German subsidiary. In the future, DAS Solar German subsidiary will become the.
The US pharmaceutical giant Merck Sharp & Dohme (MSD) s China branch announced on Wednesday that, to meet the needs of Chinese patients and help China s fight against COVID-19, MSD launched licensing negotiations with Sinopharm to manufacture and supply molnupiravir in China.
DAS Solar announces establishment of German subsidiary pv-tech.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pv-tech.org Daily Mail and Mail on Sunday newspapers.
Molnupiravir, a COVID-19 drug developed by US pharmaceutical company Merck is expected to go into market in China on Friday, according to Liu Yong, president of Sinopharm Group.
China’s first oral anti-COVID-19 drug Azvudine will be covered by China s national medical insurance system after negotiations, China s National Healthcare Security Administration said Sunday evening.